|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 9/24 | (2006.01) |
| A61K 31/192 | (2006.01) |
| (11) | Patento numeris | 3359139 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15791391.4 |
| Europos patento paraiškos padavimo data | 2015-10-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/054873 |
| Data | 2015-10-09 |
| (87) | Numeris | WO 2017/062027 |
| Data | 2017-04-13 |
| (72) |
SIRIHORACHAI, Rachan , US
ROSAR, Paul , US
|
| (73) |
Bayer HealthCare LLC ,
100 Bayer Boulevard
PO Box 915, Whippany, NJ 07981,
US
|
| (54) | MODIFIED RELEASE FORMULATION OF NAPROXEN SODIUM |
| MODIFIED RELEASE FORMULATION OF NAPROXEN SODIUM |